Showing 861-870 of 23043 results for "".
Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
https://reachmd.com/programs/project-oncology/evaluating-gene-therapy-for-sickle-cell-disease-advantages-and-barriers/36234/Gene therapy is redefining the treatment landscape for sickle cell disease, with approaches like gene addition, gene editing, and fetal hemoglobin induction showing promise in reducing or even eliminating symptoms. However, while these therapies offer some advantages over allogeneic stem cell transpImproving Health Literacy to Empower Adolescents With Sickle Cell Disease
https://reachmd.com/programs/project-oncology/improving-health-literacy-to-empower-adolescents-with-sickle-cell-disease/35927/Health literacy directly influences outcomes for patients with sickle cell disease, especially during the critical transition from pediatric to adult care. Validated tools to help assess comprehension and simplified, patient-informed education materials are essential for optimal care. HearDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
https://reachmd.com/programs/neurofrontiers/disparities-in-dmt-access-women-with-ms-are-less-likely-to-receive-treatment/18046/DMTs are an effective option for patients with MS, but according to a recent study, women are less likely to receive DMT treatment.A Strategic Framework for Technology Adoption in Aesthetic Practices
https://reachmd.com/programs/modern-aesthetics/a-strategic-framework-for-technology-adoption-in-aesthetic-practices/56628/How disciplined evaluation, operational alignment, and patient-centered decision-making drive sustainable growth across multi-location aesthetic organizationsDriving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
https://reachmd.com/programs/cme/driving-progress-in-cardiology-exploring-the-role-of-fxi-in-acute-coronary-syndromes-beyond/32980/Don’t miss this broadcast replay on the potential role of factor XI inhibition in acute coronary syndrome, Afib, and secondary stroke prevention.New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
https://reachmd.com/programs/cme/new-and-emerging-pah-therapies-and-approaches-a-mixture-of-hope-and-complexity/36095/There are new and emerging therapies for PAH. Hear our experts discuss treatment approaches and why making the right diagnosis is key for selecting and individualizing therapy.Leveraging CGM to Its Full Potential in People with T2D
https://reachmd.com/programs/cme/cgm-full-potential-t2d/50980/Continuous glucose monitoring (CGM) has been widely used in individuals with type 1 diabetes (T1D), and evolving guidelines increasingly recommend its use for those with type 2 diabetes (T2D) as well. However, despite these updated recommendations, real-world adoption to support T2D management has rMeasuring Your Cost Per Lead: It’s So 2019
https://modernaesthetics.com/topics/practice-development/measuring-your-cost-per-lead-its-so-2019/35167/How to assign truly meaningful data about the cost of each bookingThe Future of HNSCC: Aligning Teams, Transforming Care
https://reachmd.com/programs/cme/The-Future-of-HNSCC-Aligning-Teams-Transforming-Care/54394/Practice-changing data in resectable HNSCC? Experts unpack KEYNOTE-689, NIVOPOSTOP, and how to implement perioperative immunotherapy.IBS and Functional GI Disorders (FGIDs)
https://reachmd.com/programs/gi-insights/ibs-and-functional-gi-disorders-fgids/7424/Host Dr. Jay Goldstein discusses the latest in IBS & Functional GI Disorders (FGIDs) with guest expert Dr. Douglas Drossman of the Drossman Center for the Education and Practice of Integrated Care. Dr. Drossman is Professor Emeritus in the departments of Gastroenterology and Psychiatry at the Ce